The effect of vitamin C supplement in the treatment of urinary tract infection in children

The effect of vitamin C supplementation in the treatment of urinary tract infection in children

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201110307942N1

Enrollment

154

Registered

2012-04-17

Start date

2011-09-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary tract infection. Urinary tract infection, site not specified

Interventions

Intervention 1: Control group:We will priscribe routin medication on UTI including cefriaxon 50-75mg/kg/daily/iv/q12h for 2 days and following by cefixime 12mg/kg/daily/q12h for 12 days, orally. Inter

Treatment - Drugs

Control group:We will priscribe routin medication on UTI including cefriaxon 50-75mg/kg/daily/iv/q12h for 2 days and following by cefixime 12mg/kg/daily/q12h for 12 days, orally.

"Case control : We will priscribe routin medication for UTI plus Vit C 250 mg/daily for 14 days, orally.”

Eligibility

Sex/Gender

Female

Age

3 Years to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: All of girls who are between age 3 to 12 that diagnosed as an urinary infection by pediatrician are eligible to enter to study. Exclusion criteria: The girls who are less than 3 years and more than 12 years ; All sick children whose parents disagree to cooperate ; Patients with renal anomalies ; Patients with kidney stones ; Positive urine culture with several types of germs ; Any drug resistant ; Patients who are under other medications ; history of recurrent urinary tract infection ; The inappropriate use of other supplements

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Fever. Timepoint: Daily; until 14 days. Method of measurement: Clinical questionnaire.;Urine culture. Timepoint: 48 hours and 10 days after treatment. Method of measurement: Coloni Count.;Abdominal pain. Timepoint: Daily; until 14 days. Method of measurement: Clinical questionnaire.;Dysuria. Timepoint: Daily; until 14 days. Method of measurement: Clinical questionnaire.;Frequent urination. Timepoint: Daily; until 14 days. Method of measurement: Clinical questionnaire.;Urinary incontinence. Timepoint: Daily; until 14 days. Method of measurement: Clinical questionnaire.	—

Measure

Time frame

Fever. Timepoint: Daily; until 14 days. Method of measurement: Clinical questionnaire.;Urine culture. Timepoint: 48 hours and 10 days after treatment. Method of measurement: Coloni Count.;Abdominal pain. Timepoint: Daily; until 14 days. Method of measurement: Clinical questionnaire.;Dysuria. Timepoint: Daily; until 14 days. Method of measurement: Clinical questionnaire.;Frequent urination. Timepoint: Daily; until 14 days. Method of measurement: Clinical questionnaire.;Urinary incontinence. Timepoint: Daily; until 14 days. Method of measurement: Clinical questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactYousefi P . Dr

Arak University of Medical Sciences and Health Services

parsayousefichaijan@yahoo.com+98 86 1313 5075

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026